Great presentation, acceptance into the Healey platform seems to be the catalyst to look out for in the next few months. Would appreciate if anyone could provide some analysis onto the slower decline in ALSFRS-R score. Why does the Monepantel score have a much wider indicator, particularly towards the latter months (talking about the green circle and its bracket). Any insight would be appreciated, I'm new to med stocks.
Ann: PharmAust Presentation, page-21
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 16.8¢ | $151.1K | 877.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 54714 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 371375 | 7 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |